A Study to Demonstrate the Efficacy and Safety of Motilitone®
Launched by DONG-A ST CO., LTD. · Mar 20, 2013
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Roman III criteria
- • One or more conditions are applied: epigastralgia, burning feelings in the solar plexus early satiety, uncomfortable fullness
- • No organic lesion
- Exclusion Criteria:
- • has been administered or was administered within a month
- • had a surgery that might affect gastrointestinal motility
- • Tegaserod
About Dong A St Co., Ltd.
Dong-A ST Co., Ltd. is a leading pharmaceutical and biotechnology company based in South Korea, dedicated to the research, development, and commercialization of innovative therapeutic solutions. With a robust portfolio spanning various therapeutic areas, including neurology, oncology, and cardiovascular health, Dong-A ST is committed to advancing healthcare through cutting-edge clinical research and high-quality products. The company emphasizes a patient-centered approach, collaborating with global partners to enhance treatment options and improve health outcomes worldwide. Through its rigorous clinical trials and commitment to scientific excellence, Dong-A ST strives to contribute meaningfully to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suwon, , Korea, Republic Of
Patients applied
Trial Officials
Myung Kyu Choi, M.D., Ph.D.
Principal Investigator
The Catholic University of Korea
Kyu Chan Huh, M.D., Ph.D.
Principal Investigator
Konyang University Hospital
Sung Kook Kim, M.D., Ph.D.
Principal Investigator
Kyungpook National University Hospital
Kyung Sik Park, M.D., Ph.D.
Principal Investigator
Keimyung University Dongsan Medical Center
Joong Gu Gweon, M.D.,Ph.D.
Principal Investigator
Daegu Catholic University Medical Center
Geun Am Song, M.D., Ph.D.
Principal Investigator
Busan National University Hospital
Soo Jin Hong, M.D., Ph.D.
Principal Investigator
Soonchunhyang University Hospital
Na Young Kim, M.D., Ph.D.
Principal Investigator
Seoul National University Bundang Hospital
Jung Il Son, M.D., Ph.D.
Principal Investigator
Kangbuk Samsung Hospital
Poong Yul Lee, M.D., Ph.D.
Principal Investigator
Samsung Medical Center
Joon Sung Lee, M.D., Ph.D.
Principal Investigator
Soonchunhyang University Hospital
Hoon Yong Jung, M.D., Ph.D.
Principal Investigator
Asan Medical Center
Hyo Jin Park, M.D., Ph.D.
Principal Investigator
Gangnam Severance Hospital
Yong Chan Lee, M.D., Ph.D.
Principal Investigator
Severance Hospital
Suk Chae Choi, M.D., Ph.D.
Principal Investigator
Wonkwang Medical Center
Hye Kyung Jung, M.D., Ph.D.
Principal Investigator
Iwha Womans Unversity Mokdong Hospital
Sam Ryong Ji, M.D., Ph.D.
Principal Investigator
Inje University
Jong Sun Ryu, M.D., Ph.D.
Principal Investigator
Chonnam National University Hospital
Oh Young Lee, M.D., Ph.D.
Principal Investigator
Hanyang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials